[india-drug] 2003 SEAM Conference

["Dr. Leela McCullough" <leela@usa.healthnet.org>]

2003 SEAM Conference: Targeting Improved Access to Essential Medicines
----------------------------------------------------------------------

Dar es Salaam, United Republic of Tanzania

June 16-18, 2003

The 2003 Conference for the Strategies for Enhancing Access to 
Medicines (SEAM) Program will be held in Dar es Salaam, United Republic
of Tanzania, June 16-18, 2003. Funded by the Bill & Melinda Gates
Foundation and presented in collaboration with the Ministry of Health
of the United Republic of Tanzania, the World Health Organizations
Department of Essential Drugs and Medicines Policy, the Rockefeller
Foundation, the International Network for Rational Use of Drugs, and
Management Sciences for Health Rational Pharmaceutical Management Plus
Program (funded by USAID), the 2003 Conference will serve as a forum
for discussion of a wide range of pharmaceuticals-related intervention
strategies that are of concern to developing nations. The conference
will also provide the opportunity to share information about the
activities of the SEAM Program, which focus on enhancing access to
essential medicines through collaboration between the private and
public sectors.

The conference will feature plenary and parallel track presentations on

six  major topics, followed by roundtable discussion groups for each
topic. 
Poster presentations will provide the opportunity for conference 
participants to share information about their initiatives, research, 
and experience. Parallel topic tracks will include
    * Pharmaceutical product prices, including country-level 
determinants, dynamics, monitoring, and policy
    * Pharmaceutical procurement, including national and cross-national

pooled procurement strategies
    * Pharmaceutical product quality assurance, focusing on strategies 
for resource-limited settings, including prequalification of products
and suppliers and the role of identification (screening) tests and 
pharmacopoeial monograph testing
    * Pharmaceutical distribution systems, focusing on strategies for 
ensuring access to essential medicines in rural and peri-urban areas
    * Rational use of medicines, including information access, product 
selection, and appropriate prescribing and patient use
    * Human resources for the pharmaceutical sector, including new 
approaches to staffing and training in health product supply management

Although the majority of participants will attend the conference by
invitation, a number of open registration slots will be available on a
first-come, first-served basis. Individuals interested in attending
should submit a registration request as early as possible. All
registration requests will be placed, in the order received, on the
Conference priority list. For further information about the
registration process, please visit the SEAM Web site
(<http://www.msh.org/seam>www.msh.org/seam) after January 10, 2003.

Information on abstract submissions for poster presentations will also 
be available on the SEAM Web site after January 10. Individuals
interested in submitting poster abstracts for consideration by the
Program Committee should plan their submissions around one of the six
topics listed above and be prepared to submit an abstract by February
28, 2003.

For further information on the conference, please contact John Vivalo 
(<mailto: jvivalo@msh.org).





________________________________________________________________________
Missed your favourite TV serial last night? Try the new, Yahoo! TV.
       visit http://in.tv.yahoo.com
The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@usa.healthnet.org